{
    "title": "Fulcrum Therapeutics begins trial of muscle disorder drug for COVID-19 patients",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-8455105/Fulcrum-Therapeutics-begins-trial-muscle-disorder-drug-COVID-19-patients.html",
    "date": "2020-06-24",
    "keywords": [
        "losmapimod",
        "trial",
        "latestage",
        "disorder",
        "drug",
        "year",
        "fulcrum",
        "june",
        "wednesday",
        "muscle",
        "covid19",
        "company",
        "glaxosmithkline",
        "plc",
        "placebo",
        "httpsbwnewspr2vejvn7",
        "topline",
        "quarter",
        "proportion",
        "failure",
        "day",
        "dose",
        "standard",
        "care",
        "treatment",
        "musclewasting",
        "muscular",
        "dystrophy",
        "reporting",
        "roy",
        "bengaluru",
        "editing"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}